Nxera Pharma Co., Ltd. (SOLTF) Financials
SOLTF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 808.0 million | 412.5 million |
| March 31, 2026 | 840.0 million | 438.8 million |
| Dec. 31, 2025 | 861.1 million | 471.4 million |
| Sept. 30, 2025 | 988.1 million | 538.1 million |
SOLTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 34.0 million | ? |
| March 31, 2026 | -12.3 million | ? |
| Dec. 31, 2025 | -1.7 million | ? |
| Sept. 30, 2025 | -21.1 million | ? |
SOLTF Net Income
No data available :(
SOLTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 108.3 million | 271.3 million | 15.2 million |
| March 31, 2026 | 73.1 million | 288.7 million | 20.9 million |
| Dec. 31, 2025 | 130.1 million | 323.9 million | 28.1 million |
| Sept. 30, 2025 | 195.1 million | 367.4 million | 19.6 million |
SOLTF Shares Outstanding
SOLTF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 317406 | 18.1 million | 20.6 million | - |
| March 31, 2026 | 1.9 million | 19.1 million | 22.5 million | - |
| Dec. 31, 2025 | 939162 | 20.9 million | 24.4 million | - |
| Sept. 30, 2025 | 695941 | 25.5 million | 26.3 million | - |
SOLTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 46.7 million | 13.2 million |
| March 31, 2026 | 70.9 million | 7.0 million |
| Dec. 31, 2025 | 49.6 million | 13.1 million |
| Sept. 30, 2025 | 46.3 million | 18.3 million |
SOLTF
Price: $5.01
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.56 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 457.8 million